Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
4.070
+0.010 (0.25%)
At close: Jun 18, 2026, 4:00 PM EDT
4.084
+0.014 (0.34%)
After-hours: Jun 18, 2026, 6:50 PM EDT
Opus Genetics Employees
As of December 31, 2025, Opus Genetics had 28 total employees, including 27 full-time and 1 part-time employees. The number of employees increased by 10 or 55.56% compared to the previous year.
Employees
28
Change (1Y)
10
Growth (1Y)
55.56%
Revenue / Employee
$427,964
Profits / Employee
-$3,819,000
Market Cap
331.28M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 28 | 10 | 55.56% | 27 | 1 |
| Dec 31, 2024 | 18 | 4 | 28.57% | 18 | 0 |
| Dec 31, 2023 | 14 | 5 | 55.56% | 14 | 0 |
| Dec 31, 2022 | 9 | 1 | 12.50% | 9 | 0 |
| Dec 31, 2021 | 8 | 3 | 60.00% | 8 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Vanda Pharmaceuticals | 533 |
| Abeona Therapeutics | 226 |
| Rocket Pharmaceuticals | 202 |
| OmniAb | 89 |
| Silence Therapeutics | 88 |
| Upstream Bio | 75 |
| Atea Pharmaceuticals | 55 |
| Zura Bio | 40 |
IRD News
- 2 days ago - Opus Genetics assumed with a Buy at Chardan - TheFly
- 3 days ago - Opus Genetics Highlights Five Gene Therapy Programs Targeting Significant Unmet Need in Patients with Inherited Retinal Diseases - GlobeNewsWire
- 3 days ago - Opus Genetics Transcript: R&D Day 2026 - Transcripts
- 3 days ago - Opus Genetics Slides: FY 2026 - Filings
- 7 days ago - Opus Genetics management to meet with BTIG - TheFly
- 14 days ago - Opus Genetics registers to sell 2.68M shares of common stock for holders - TheFly
- 14 days ago - Opus Genetics Registration statement: Registration filing - Filings
- 15 days ago - Opus Genetics initiated with a Buy at Guggenheim - TheFly